Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan B Corcoran

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Genome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2021
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-ResponseAparna R Parikh, Ryan B Corcoran
Molecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B Corcoran
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B Corcoran
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Expanded RAS: refining the patient populationChloe E Atreya, Ryan B Corcoran, Scott Kopetz
Oncotarget|April 21, 2011
Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancersRyan B Corcoran, Jeffrey Settleman, Jeffrey A Engelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
The PI3K pathway as drug target in human cancerKevin D Courtney, Ryan B Corcoran, Jeffrey A Engelman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer ManagementChristopher H Lieu, Ryan B Corcoran, Michael J Overman
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Hedgehog signal transduction by Smoothened: pharmacologic evidence for a 2-step activation processRajat Rohatgi, Ljiljana Milenkovic, Ryan B Corcoran, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Genome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2021
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-ResponseAparna R Parikh, Ryan B Corcoran
Molecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B Corcoran
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B Corcoran
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Expanded RAS: refining the patient populationChloe E Atreya, Ryan B Corcoran, Scott Kopetz
Oncotarget|April 21, 2011
Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancersRyan B Corcoran, Jeffrey Settleman, Jeffrey A Engelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
The PI3K pathway as drug target in human cancerKevin D Courtney, Ryan B Corcoran, Jeffrey A Engelman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer ManagementChristopher H Lieu, Ryan B Corcoran, Michael J Overman
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Hedgehog signal transduction by Smoothened: pharmacologic evidence for a 2-step activation processRajat Rohatgi, Ljiljana Milenkovic, Ryan B Corcoran, et al.
Pageof 11